Your browser doesn't support javascript.
loading
Author Correction: Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells.
Klawitter, Sabine; Fuchs, Nina V; Upton, Kyle R; Muñoz-Lopez, Martin; Shukla, Ruchi; Wang, Jichang; Garcia-Cañadas, Marta; Lopez-Ruiz, Cesar; Gerhardt, Daniel J; Sebe, Attila; Grabundzija, Ivana; Merkert, Sylvia; Gerdes, Patricia; Pulgarin, J Andres; Bock, Anja; Held, Ulrike; Witthuhn, Anett; Haase, Alexandra; Sarkadi, Balázs; Löwer, Johannes; Wolvetang, Ernst J; Martin, Ulrich; Ivics, Zoltán; Izsvák, Zsuzsanna; Garcia-Perez, Jose L; Faulkner, Geoffrey J; Schumann, Gerald G.
Affiliation
  • Klawitter S; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Fuchs NV; Division of Inborn Metabolic Diseases, University Children's Hospital, D-69120, Heidelberg, Germany.
  • Upton KR; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Muñoz-Lopez M; Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
  • Shukla R; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia.
  • Wang J; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
  • Garcia-Cañadas M; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK.
  • Lopez-Ruiz C; Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
  • Gerhardt DJ; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
  • Sebe A; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
  • Grabundzija I; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia.
  • Merkert S; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Gerdes P; Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
  • Pulgarin JA; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
  • Bock A; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, Brisbane, Queensland, 4102, Australia.
  • Held U; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain.
  • Witthuhn A; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Haase A; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Sarkadi B; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
  • Löwer J; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
  • Wolvetang EJ; Department of Biophysics and Radiation Biology, Semmelweis University, H-1094, Budapest, Hungary.
  • Martin U; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Ivics Z; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, 4072, Australia.
  • Izsvák Z; Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery; REBIRTH, Cluster of Excellence, Hannover Medical School, D-30625, Hannover, Germany.
  • Garcia-Perez JL; Division of Medical Biotechnology, Paul-Ehrlich-Institute, D-63225, Langen, Germany.
  • Faulkner GJ; Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany.
  • Schumann GG; Department of Human DNA Variability, Pfizer/University of Granada and Andalusian Regional Government Center for Genomics and Oncology (GENYO), PTS Granada, 18016, Granada, Spain. jlgp@genyo.es.
Nat Commun ; 9(1): 5398, 2018 12 19.
Article in En | MEDLINE | ID: mdl-30568248
This Article contains an error in the author affiliations. The correct affiliation for author Ruchi Shukla is 'MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK', and is not 'Mater Research Institute - University of Queensland, TRI Building, Woolloongabba QLD 4102, Australia'.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Document type: Article Affiliation country: Germany Country of publication: United kingdom